Pamlectabart
Product Specifications
Target
TNF
Related Pathways
Apoptosis
Purity
0.966
Bioactivity
Pamlectabart is a humanised antibody targeting TNFRSF17/BCMA, which can be used to synthesise the antibody-drug conjugate (ADC) Pamlectabart tismanitin for the study of multiple myeloma.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6207959-01 0.1 mL
PLCL2 (Phospholipase C-like 2, FLJ13484, KIAA1092, PLCE2) (MaxLight 490)
Ask
View Details 
MBS6207959-02 5x 0.1 mL
PLCL2 (Phospholipase C-like 2, FLJ13484, KIAA1092, PLCE2) (MaxLight 490)
Ask
View Details 